Thyroid pharmaceutical ingredient recalled for failed stability specifications
Specialty Process Labs is recalling S.P.Labs Thyroid, Full Strength (NDC 81305-500-01) due to failed stability specifications. The ingredient was distributed nationwide for pharmaceutical manufacturing use.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a pharmaceutical ingredient with documented failed stability specifications, constituting a risk-of-harm product where injury has not yet been reported. The FDA Class II classification and lack of reported illnesses or injuries place it at the High severity level per the rubric.
Plain-English summary
Specialty Process Labs LLC is recalling S.P.Labs Thyroid, Full Strength (NDC 81305-500-01, Lot #H22212-FSV) due to failed stability specifications. This is an active pharmaceutical ingredient intended for manufacturing, processing, or repackaging use by pharmaceutical companies, not for direct consumer use.
The recalled lot was distributed nationwide in 1.0 kg pack sizes (26 units total) with an expiration date of November 2024. Pharmaceutical manufacturers and repackagers who received this ingredient should discontinue use and contact Specialty Process Labs for return or disposal instructions.
The recalled product
- Product
- S.P.Labs, Thyroid, Full Strength, Rx only, For Manufacturing, Processing or Repackaging Use Only, Specialty Process Labs, Phoenix, AZ 85034, NDC 81305-500-01.
- Manufacturer
- Specialty Process Labs LLC
- Category
- Drug — Pharmaceutical Ingredient
- Hazard
- stability-failure
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: H22212-FSV
- Exp: 11/21/2024 1.0 kg pack size.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01